Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Insulin-like Growth Factor-I Receptor Signaling Pathway Induces Resistance to the Apoptotic Activities of SCH66336 (Lonafarnib) through Akt/Mammalian Target of Rapamycin–Mediated Increases in Survivin Expression

Clin Cancer Res (2008) 14 (5): 1581–1589.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Treatment failure shortcomings, possible causes and upcoming phyto-optimism in oral cancer
  • Rajakishore Mishra
The Applied Biology & Chemistry Journal 4.
IGF‑1 inhibits palmitic acid‑induced mitochondrial apoptosis in macrophages
  • Wanying Tang
  • Ming Zhang
  • Yu Wang
  • Dan Ma
  • Mi Hu
  • Yangkai Zhang
  • Huiling Lin
  • Weiwei Jiang
  • Yuxin Ouyang
  • Liping Jiang
  • Pingping He
  • Guojun Zhao
  • Xinping Ouyang
Molecular Medicine Reports (2023) 28 (6)
The combined therapy of mesenchymal stem cell transplantation and resveratrol for diabetes: Future applications and challenges
  • Yanjie Yang
  • Tong Lei
  • Wangyu Bi
  • Zhuangzhuang Xiao
  • Xiaoshuang Zhang
  • Hongwu Du
Life Sciences (2022) 301: 120563.
The identities of insulin signaling pathway are affected by overexpression of Tau and its phosphorylation form
  • Ningtian Ma
  • Yuyang Liang
  • Lingyun Yue
  • Pu Liu
  • Yuxia Xu
  • Cuiqing Zhu
Frontiers in Aging Neuroscience (2022) 14
Autophagy as a Potential Therapy for Malignant Glioma
  • Angel Escamilla-Ramírez
  • Rosa A. Castillo-Rodríguez
  • Sergio Zavala-Vega
  • Dolores Jimenez-Farfan
  • Isabel Anaya-Rubio
  • Eduardo Briseño
  • Guadalupe Palencia
  • Patricia Guevara
  • Arturo Cruz-Salgado
  • Julio Sotelo
  • Cristina Trejo-Solís
Pharmaceuticals (2020) 13 (7): 156.
FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosis
  • Arvind Ponnusamy
  • Smeeta Sinha
  • Gareth D. Hyde
  • Samantha J. Borland
  • Rebecca F. Taylor
  • Emma Pond
  • Heather J. Eyre
  • Colette A. Inkson
  • Andrew Gilmore
  • Nick Ashton
  • Philip A. Kalra
  • Ann E. Canfield
  • Yin Tintut
PLOS ONE (2018) 13 (4): e0196232.
Prodigiosin produced bySerratia marcescensinhibits expression of MMP-9 and survivin and promotes caspase-3 activation with induction of apoptosis in acute lymphoblastic leukaemia cells
  • M.R. Sam
  • S. Ghoreishi
Journal of Applied Microbiology (2018) 125 (4): 1017.
Omega-3 fatty acid DHA modulates p53, survivin, and microRNA-16-1 expression in KRAS-mutant colorectal cancer stem-like cells
  • Mohammad Reza Sam
  • Mohammad Tavakoli-Mehr
  • Reza Safaralizadeh
Genes & Nutrition (2018) 13 (1)
The combination of everolimus and terameprocol exerts synergistic antiproliferative effects in endometrial cancer: molecular role of insulin-like growth factor binding protein 2
  • Angel Chao
  • Chiao-Yun Lin
  • Ren-Chin Wu
  • Yun-Shien Lee
  • Li-Yu Lee
  • Chia-Lung Tsai
  • Lan-Yan Yang
  • Hsuan Liu
  • Shu-Jen Chen
  • Tzu-Hao Wang
  • Chyong-Huey Lai
Journal of Molecular Medicine (2018) 96 (11): 1251.
YM155 sensitizes non-small cell lung cancer cells to EGFR-tyrosine kinase inhibitors through the mechanism of autophagy induction
  • Chun-Hua Dai
  • Yang Shu
  • Ping Chen
  • Jian-Nong Wu
  • Li-Haun Zhu
  • Rong-Xia Yuan
  • Wei-Guo Long
  • Yu-Min Zhu
  • Jian Li
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) 1864 (12): 3786.
Targeting survivin with prodigiosin isolated from cell wall of Serratia marcescens induces apoptosis in hepatocellular carcinoma cells
  • RA Yenkejeh
  • MR Sam
  • M Esmaeillou
Human & Experimental Toxicology (2017) 36 (4): 402.
Type I insulin-like growth factor receptor signaling in hematological malignancies
  • Deeksha Vishwamitra
  • Suraj Konnath George
  • Ping Shi
  • Ahmed O. Kaseb
  • Hesham M. Amin
Oncotarget (2017) 8 (1): 1814.
N-Hydroxyphthalimide exhibits antitumor activity by suppressing mTOR signaling pathway in BT-20 and LoVo cells
  • Min Wang
  • Ankun Zhou
  • Tao An
  • Lingmei Kong
  • Chunlei Yu
  • Jianmei Liu
  • Chengfeng Xia
  • Hongyu Zhou
  • Yan Li
Journal of Experimental & Clinical Cancer Research (2016) 35 (1)
Mutation R273H confers p53 a stimulating effect on the IGF-1R-AKT pathway via miR-30a suppression in breast cancer
  • Fangdong Guo
  • Hongshen Chen
  • Jian Chang
  • Lin Zhang
Biomedicine & Pharmacotherapy (2016) 78: 335.
Survivin in survival of hepatocellular carcinoma
  • Changqing Su
Cancer Letters (2016) 379 (2): 184.
BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549
  • S. Elizabeth Franks
  • Robert A. Jones
  • Ritesh Briah
  • Payton Murray
  • Roger A. Moorehead
BMC Research Notes (2016) 9 (1)
Management of EGFR -mutant non-small-cell lung cancer patients after first-line reversible EGF receptor-tyrosine kinase inhibitors
  • Anna Manzo
  • Carminia Maria Della Corte
  • Lucia Festino
  • Morena Fasano
  • Fortunato Ciardiello
  • Floriana Morgillo
Lung Cancer Management (2014) 3 (1): 77.
Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin
  • Da-Liang Ou
  • Bin-Shyun Lee
  • Liang-In Lin
  • Jun-Yang Liou
  • Sheng-Chieh Liao
  • Chiun Hsu
  • Ann-Lii Cheng
Molecular Cancer (2014) 13 (1)
Neutral sphingomyelinase 2 modulates cytotoxic effects of protopanaxadiol on different human cancer cells
  • Bonggoo Park
  • Yong-Moon Lee
  • Jae-Sung Kim
  • Youl Her
  • Ju Hee Kang
  • Seung-Hyun Oh
  • Hwan-Mook Kim
BMC Complementary and Alternative Medicine (2013) 13 (1)
Function of Survivin in Trophoblastic Cells of the Placenta
  • Cornelia Muschol-Steinmetz
  • Alexandra Friemel
  • Nina-Naomi Kreis
  • Joscha Reinhard
  • Juping Yuan
  • Frank Louwen
  • Ana Claudia Zenclussen
PLoS ONE (2013) 8 (9): e73337.
A novel antitumor activity of deguelin targeting the insulin-like growth factor (IGF) receptor pathway via up-regulation of IGF-binding protein-3 expression in breast cancer
  • Young-Ah Suh
  • Jai-Hyun Kim
  • Myung A Sung
  • Hye-Jin Boo
  • Hye Jeong Yun
  • Sun-Hye Lee
  • Hyo-Jong Lee
  • Hye-Young Min
  • Young-Ger Suh
  • Kyu-Won Kim
  • Ho-Young Lee
Cancer Letters (2013) 332 (1): 102.
Histone deacetylase inhibitors enhance the apoptotic activity of insulin‐like growth factor binding protein‐3 by blocking PKC‐induced IGFBP‐3 degradation
  • Seung Hyun Oh
  • Young Mi Whang
  • Hye‐Young Min
  • Seung Ho Han
  • Ju‐Hee Kang
  • Ki‐Hoon Song
  • Bonnie S. Glisson
  • Yeul Hong Kim
  • Ho‐Young Lee
International Journal of Cancer (2012) 131 (10): 2253.
Lonafarnib for cancer and progeria
  • Nan Soon Wong
  • Michael A Morse
Expert Opinion on Investigational Drugs (2012) 21 (7): 1043.
A multiplicity of anti‐invasive effects of farnesyl transferase inhibitor SCH66336 in human head and neck cancer
  • Seung Hyun Oh
  • Ju‐Hee Kang
  • Jong Kyu Woo
  • Ok‐Hee Lee
  • Edward S. Kim
  • Ho‐Young Lee
International Journal of Cancer (2012) 131 (3): 537.
Survivin in Solid Tumors: Rationale for Development of Inhibitors
  • David N. Church
  • Denis C. Talbot
Current Oncology Reports (2012) 14 (2): 120.
Rapamycin decreases survivin expression to induce NSCLC cell apoptosis under hypoxia through inhibiting HIF-1α induction
  • Bin Chen
  • Sun Yuping
  • Jian Ni
Molecular Biology Reports (2012) 39 (1): 185.
Combination of Farnesyltransferase and Akt Inhibitors Is Synergistic in Breast Cancer Cells and Causes Significant Breast Tumor Regression in ErbB2 Transgenic Mice
  • Maria E. Balasis
  • Kara D. Forinash
  • Y. Ann Chen
  • William J. Fulp
  • Domenico Coppola
  • Andrew D. Hamilton
  • Jin Q. Cheng
  • Saïd M. Sebti
Clinical Cancer Research (2011) 17 (9): 2852.
Protein-intrinsic and signaling network-based sources of resistance to EGFR- and ErbB family-targeted therapies in head and neck cancer
  • Ranee Mehra
  • Ilya G. Serebriiskii
  • Roland L. Dunbrack
  • Matthew K. Robinson
  • Barbara Burtness
  • Erica A. Golemis
Drug Resistance Updates (2011) 14 (6): 260.
Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1–mediated transcriptional events
  • Jai-Hyun Kim
  • Dong Soon Choi
  • Ok-Hee Lee
  • Seung-Hyun Oh
  • Scott M. Lippman
  • Ho-Young Lee
Blood (2011) 118 (9): 2622.
Targeting survivin in cancer: the cell-signalling perspective
  • Jagat R. Kanwar
  • Sishir K. Kamalapuram
  • Rupinder K. Kanwar
Drug Discovery Today (2011) 16 (11-12): 485.
Targeting protein prenylation for cancer therapy
  • Norbert Berndt
  • Andrew D. Hamilton
  • Saïd M. Sebti
Nature Reviews Cancer (2011) 11 (11): 775.
Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expression
  • Young-Sun Kim
  • Hyeon-Ok Jin
  • Sung-Keum Seo
  • Sang Hyeok Woo
  • Tae-Boo Choe
  • Sungkwan An
  • Seok-Il Hong
  • Su-Jae Lee
  • Kee-Ho Lee
  • In-Chul Park
Biochemical Pharmacology (2011) 82 (3): 216.
EGF regulates survivin stability through the Raf-1/ERK pathway in insulin-secreting pancreatic β-cells
  • Haijuan Wang
  • Katarina Gambosova
  • Zachary A Cooper
  • Michael P Holloway
  • Andrea Kassai
  • Denisse Izquierdo
  • Kelly Cleveland
  • Charlotte M Boney
  • Rachel A Altura
BMC Molecular Biology (2010) 11 (1)
Ras homologue enriched in brain is a critical target of farnesyltransferase inhibitors in non-small cell lung cancer cells
  • Hang Zheng
  • Anling Liu
  • Bin Liu
  • Minghui Li
  • Hailang Yu
  • Xiaojun Luo
Cancer Letters (2010) 297 (1): 117.
Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin
  • S Wang
  • X Huang
  • C-K Lee
  • B Liu
Oncogene (2010) 29 (29): 4225.
Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines
  • Zhenfeng Duan
  • Edwin Choy
  • David Harmon
  • Cao Yang
  • Keinosuke Ryu
  • Joseph Schwab
  • Henry Mankin
  • Francis J. Hornicek
Molecular Cancer Therapeutics (2009) 8 (8): 2122.
Rapamycin selectively reduces the association of transcripts containing complex 5′ UTRs with ribosomes in C4‐2B prostate cancer cells
  • Lynn M. Opdenaker
  • Mary C. Farach‐Carson
Journal of Cellular Biochemistry (2009) 107 (3): 473.
Comment on Shi et al.’s hypothesis: Survivin will go much further
  • Rong Wu
  • Yuecan Zeng
Medical Hypotheses (2009) 72 (3): 363.
Inhibition of hypoxia-inducible factor-1 function enhances the sensitivity of multiple myeloma cells to melphalan
  • Yongzhen Hu
  • Keita Kirito
  • Kozue Yoshida
  • Toru Mitsumori
  • Kei Nakajima
  • Yumi Nozaki
  • Satoshi Hamanaka
  • Takahiro Nagashima
  • Masae Kunitama
  • Kumi Sakoe
  • Norio Komatsu
Molecular Cancer Therapeutics (2009) 8 (8): 2329.
The Rationale and Development of Therapeutic Insulin-like Growth Factor Axis Inhibition for Lung and Other Cancers
  • D. Ross Camidge
  • Rafal Dziadziuszko
  • Fred R. Hirsch
Clinical Cancer Reviews (2009) 3 (1): 19.
The Rationale and Development of Therapeutic Insulin-like Growth Factor Axis Inhibition for Lung and Other Cancers
  • D. Ross Camidge
  • Rafal Dziadziuszko
  • Fred R. Hirsch
Clinical Lung Cancer (2009) 10 (4): 262.
New wirings in the survivin networks
  • D C Altieri
Oncogene (2008) 27 (48): 6276.
  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept